As Ozempic’s Popularity Soars, Here’s What to Know About Semaglutide and Weight Loss
The DOI matches its Crossref record.
Abstract
This Medical News article discusses chronic weight management with semaglutide, sold under the brand names Ozempic and Wegovy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Arillotta, D., Floresta, G., Guirguis, A., Corkery, J. M., Catalani, V., Martinotti, G., Sensi, S. L., & Schifano, F. (2023) · Brain Sciences · doi:10.3390/brainsci13111503 · Cited by 104
“Given their proven clinical efficacy in being associated with weight loss, which for some of these molecules is similar to bariatric surgery [12], GLP-1 RAs immediately aroused great interest [13–15].”
BackgroundEarly‐ and later‐stage persistence with antiobesity medications: A retrospective cohort study
Gasoyan, H., Pfoh, E. R., Schulte, R., Le, P., & Rothberg, M. B. (2024) · Obesity · doi:10.1002/oby.23952 · Cited by 94
Longitudinal Analysis of Obesity Drug Use and Public Awareness
Berning, P., Adhikari, R., Schroer, A. E., Jelwan, Y. A., Razavi, A. C., Blaha, M. J., & Dzaye, O. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.57232 · Cited by 78
One-Year Weight Reduction With Semaglutide or Liraglutide in Clinical Practice
Gasoyan, H., Pfoh, E. R., Schulte, R., Le, P., Butsch, W. S., & Rothberg, M. B. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.33326 · Cited by 71
Gasoyan, H., Butsch, W. S., Schulte, R., Casacchia, N. J., Le, P., Boyer, C. B., Griebeler, M. L., Burguera, B., & Rothberg, M. B. (2025) · Obesity · doi:10.1002/oby.24331 · Cited by 54
“This study captured injectable semaglutide and tirzepatide under the brand names approved by the FDA for obesity (i.e., Wegovy and Zepbound), as well as off-label use of those approved for T2D (i.e., Ozempic and Mounjaro) [14], including all starting and maintenance dosages.”
Metadata
- Authors
- Suran, M.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2023-05-16
- Volume
- 329
- Issue
- 19
- Pages
- 1627
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4367047588
- Cited by
- 64
- References
- 0
- FWCI
- 8.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: As Ozempic’s Popularity Soars, Here’s What to Know About Semaglutide and Weight Loss. https://app.cochat.ai/papers/10.1001/jama.2023.2438
- The paper
- Suran, M. (2023). As Ozempic’s Popularity Soars, Here’s What to Know About Semaglutide and Weight Loss. JAMA. https://doi.org/10.1001/jama.2023.2438
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.